Kyle Rose
Stock Analyst at Canaccord Genuity
(2.63)
# 1,977
Out of 5,172 analysts
112
Total ratings
51.61%
Success rate
13.04%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $228.63 | +96.82% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $32.34 | -16.51% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $339.76 | +28.03% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $86.30 | -17.73% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $22.57 | +214.58% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $13.79 | +59.54% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.16 | +762.07% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $12.72 | +72.96% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $67.27 | +122.98% | 17 | Jul 28, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $24 → $27 | $12.77 | +111.43% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.76 | +1,882.82% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $31.16 | -51.86% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $158.50 | -23.03% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.30 | -6.98% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.00 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $89.84 | +39.14% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $228.63
Upside: +96.82%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $32.34
Upside: -16.51%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $339.76
Upside: +28.03%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $86.30
Upside: -17.73%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $22.57
Upside: +214.58%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $13.79
Upside: +59.54%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.16
Upside: +762.07%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $12.72
Upside: +72.96%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $67.27
Upside: +122.98%
SI-BONE
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $12.77
Upside: +111.43%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $0.76
Upside: +1,882.82%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $31.16
Upside: -51.86%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $158.50
Upside: -23.03%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.30
Upside: -6.98%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $9.00
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $89.84
Upside: +39.14%